PharmD Signal

Deep dives, evidence grades, and clinical tools, all in one place.

Pharmacist Review of Pending Infection Tests Raises Appropriate Post-Discharge Antimicrobial Use

pharmacist-led transitions of caretests pending at dischargeantimicrobial stewardshipculture follow-uppost-discharge antimicrobialsretrospective pre-post studyambulatory carecommunity hospital Infectious Disease / Antimicrobials

Background Information

Pharmacists boost antimicrobial appropriateness post-discharge by 23% in a week.

Managing pending infectious disease test results post-discharge can prevent inappropriate antimicrobial use and improve patient outcomes. Appropriate antimicrobial therapy at 7 days increased from 69% to 92%, with faster transition to appropriate therapy. The study shows that pharmacist-led interventions can improve antimicrobial stewardship in transitions of care, though it is single-center and retrospective. Pharmacist-led post-discharge interventions enhance antimicrobial appropriateness and speed in achieving correct therapy.

📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report.
Subscribe for Full Access →

Authors: Covington EW, Loop MS, Park J, Lee L, Bowman M, Gunter SG

Citation: Covington EW, Loop MS, Park J, et al. Pharmacist-led Transitions of Care Intervention to Address Infectious Disease Tests Pending at Discharge (TPAD). Open forum infectious diseases. 2026;13(9):ofag585. doi:10.1093/ofid/ofag585

Article Links: PubMed · Journal / DOI · Free Full Text (PMC)

🎓
Reviewed by a licensed pharmacist
Every analysis is reviewed and approved by a licensed pharmacist before publication, ensuring clinical accuracy and relevance.
Accurate and up-to-date information is our highest priority.
If you spot an error, please suggest a correction. If there is a topic you want covered, tell us and we will look at it.
Thanks for the feedback!
🔒
Deep Analysis: Subscribers Only
Subscribers receive access to a complete clinical analysis, available online and as a downloadable PDF.
Executive Summary
Study Design
Patient Population
Primary Outcomes
Secondary Outcomes & Safety Profile
Pharmacist Implications
Clinical Pearls
Limitations
Controversies & Evidence Gaps
Cost & Logistics
Want the full analysis?

Subscribe to PharmD Signal for unrestricted access to every deep analysis, plus PDF reports, GRADE evidence grades, and pharmacist implications for every article we publish.

Become a Subscriber →